Sustainability Report

Overview

The report describes ScinoPharm's 2024 sustainability governance, environmental performance, and social initiatives. It reports consolidated Scope 1, Scope 2, and partial Scope 3 emissions covering the parent and two subsidiaries, alongside a goal to reduce Scope 1 and 2 emissions by 42% by 2030. The company highlights solar generation, water conservation, waste reduction, climate-risk management, and adoption of GHG Protocol, TCFD, IFRS S2, GRI, and SASB reporting practices. Social disclosures cover 740 employees, diversity, training, occupational safety, community engagement, and a limited assurance engagement over selected indicators.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview